Cambridge, United Kingdom

Frieder Haenisch

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Cambridge. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frieder Haenisch. Retrieved from https://idiyas.com/inventor/frieder-haenisch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frieder Haenisch: Innovator in Biomarker Research

Introduction

Frieder Haenisch is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biomarker research, particularly in relation to mental health disorders. His work focuses on the diagnosis and monitoring of bipolar disorder, showcasing his commitment to advancing medical science.

Latest Patents

Haenisch holds a patent for "Serum biomarker panels for bipolar disorder." This invention relates to biomarkers and methods for diagnosing or monitoring bipolar disorder, or a predisposition to it. His innovative approach aims to improve the accuracy and efficiency of diagnosing this complex condition.

Career Highlights

Frieder Haenisch is affiliated with the University of Cambridge, where he conducts his research. His work has garnered attention for its potential impact on mental health diagnostics. With 1 patent to his name, he continues to push the boundaries of scientific understanding in his field.

Collaborations

Haenisch collaborates with esteemed colleagues, including Sabine Bahn and Jason Cooper. Their combined expertise enhances the research efforts at the University of Cambridge, fostering an environment of innovation and discovery.

Conclusion

Frieder Haenisch is a pioneering inventor whose work in biomarker research is paving the way for advancements in the diagnosis of bipolar disorder. His contributions are vital to the ongoing efforts to improve mental health care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…